PXMD PaxMedica Inc. Common Stock
0.0005USD0.00%Mkt Cap: 63132 $P/E: 0.0022d ago
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap63.13K USD
Enterprise Value-356.46K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.29M USD
Revenue/Share—
Last Price0.0005 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)166.20
EPS (Forward)-1.09
52W Range
0.00012% of range0.0200
52W High0.0200 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-540.31%
ROA-321.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.77M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-4785.23%
Net Debt-444.86K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.36
Quick Ratio0.20
Book Value/Sh-0.18 USD
Cash/Share0.0040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:17
Split DateOct 31, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.126.26M
Float—
Insiders0.00%
Institutions0.15%
Short Interest
Short Ratio0.1d
Short % Float4.07%
Short % Out.4.03%
Shares Short300.73K
Short (prev mo.)133.72K
Technical
SMA 500.0006 (-12.6%)
SMA 2000.0005 (+3.0%)
Beta-31.82
S&P 52W Chg16.45%
Avg Vol (30d)1.30K
Avg Vol (10d)95
Technical Indicators
RSI (14)44.9
MACD-0.0000
MACD Signal-0.0000
MACD Hist.-0.0000
BB Upper0.0008 USD
BB Middle0.0006 USD
BB Lower0.0004 USD
BB Width77.99%
ATR (14)0.0001 USD
Vol Ratio (20d)0.00x